Adma Biologics reported $558.38M in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Adma Biologics USD 558.38M 69.7M Jun/2025
Alnylam Pharmaceuticals USD 4.57B 352.21M Jun/2025
Dynavax Technologies USD 918.45M 27.48M Jun/2025
Takeda JPY 14T 243.81B Jun/2025